Skip to main content
CHENGZHI CO., LTD. logo

CHENGZHI CO., LTD. — Investor Relations & Filings

Ticker · 000990 ISIN · CNE0000013G2 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,266 across all filing types
Latest filing 2019-04-07 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000990

About CHENGZHI CO., LTD.

https://www.chengzhi.com.cn

Chengzhi Co., Ltd. is a high-tech enterprise focused on the development and industrialization of advanced materials, clean energy, and life sciences. The company operates a significant methanol-to-olefins (MTO) production base, providing high-purity chemical products such as ethylene, propylene, and syngas. In the field of electronic materials, it is a leading supplier of liquid crystal materials and OLED intermediates for the display industry. Its life sciences division specializes in the fermentation and production of high-value bio-products, including D-ribose and L-glutamine, serving global pharmaceutical and nutritional markets. Leveraging its research and development capabilities, the company integrates industrial manufacturing with technological innovation to provide specialized solutions in specialty chemicals and biotechnology.

Recent filings

Filing Released Lang Actions
第七届董事会2019年第二次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the company's 7th Board of Directors 2019 second extraordinary meeting. It details the meeting's convening, attendance, and voting results on matters such as acquisition and capital increase. It does not contain financial statements or detailed financial analysis but rather reports on board decisions and approvals. The document is a formal disclosure of board meeting outcomes, fitting the category of Board/Management Information (MANG). The document length is short (1410 characters), consistent with a meeting resolution announcement rather than a full report.
2019-04-07 Chinese
关于收购云南汉盟制药有限公司股权及增资的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the acquisition of equity and capital increase in Yunnan Hanmeng Pharmaceutical Co., Ltd. by Chengzhi Co., Ltd. It includes transaction overview, parties involved, financial data, asset valuation reports, pricing policies, agreements, and legal terms related to the acquisition. The content focuses on a capital/financing transaction involving share acquisition and capital injection, with detailed terms and conditions of the deal. There is no indication that this is a full annual or interim financial report, audit report, or earnings release. It is not a regulatory filing or announcement of a report publication but a substantive update on a financing and capital structure change event. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2019-04-07 Chinese
北京诚志高科生物科技有限公司拟收购云南汉盟制药有限公司股权并对其增资评估项目资产评估报告
Audit Report / Information Classification · 95% confidence The document is a detailed asset valuation report prepared by Beijing Zhuoxin Dahua Asset Appraisal Co., Ltd. for Beijing Chengzhi Gaoke Biotechnology Co., Ltd. regarding the acquisition and capital increase of Yunnan Hanmeng Pharmaceutical Co., Ltd. The report includes comprehensive sections such as the purpose of the appraisal, the scope, valuation methods (asset-based and market methods), assumptions, legal and regulatory references, detailed financial data, and the final valuation conclusions. It is a formal asset appraisal report used to support a corporate acquisition transaction. The document is not an announcement or a brief summary but a full valuation report with substantive financial and valuation analysis. This fits the category of an Audit Report / Information (AR), as it is a standalone valuation report related to an acquisition, providing detailed applied accounting principles and valuation results, but it is not a full Annual Report or Interim Report. Therefore, the appropriate classification is AR with high confidence. Q1 2019
2019-04-07 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase program. It details the number of shares repurchased, prices, total amount spent, and compliance with regulatory rules. It does not contain financial statements or comprehensive financial data but rather updates on the share buyback activity. The document length is short (1630 characters) and focuses on the progress of share repurchase, which fits the description of a Transaction in Own Shares (POS) filing rather than a full financial report or other categories.
2019-04-01 Chinese
关于公司重大仲裁事项的进展公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement regarding the progress of a significant arbitration matter involving the company. It details the arbitration case, the arbitration committee's final ruling, financial implications, and references the arbitration award document. The text does not contain financial statements or comprehensive financial data but rather provides an update on a legal proceeding and its impact on the company. This fits the definition of a Legal Proceedings Report (LTR), which covers updates on significant lawsuits or regulatory actions involving the company.
2019-04-01 Chinese
独立董事对公司第七届董事会2019年第一次临时会议相关议案的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding the pre-approval of proposals for the company's 7th Board of Directors 2019 first extraordinary meeting. It references compliance with regulatory guidelines and company bylaws, and discusses approval of a donation and related party transaction. The document is short (742 characters) and does not contain financial statements or detailed financial data. It is not a full report but an official opinion or announcement related to board meeting agenda items. This fits best under Board/Management Information (MANG), which covers announcements related to board activities and management decisions.
2019-03-25 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.